Poxel S.A. (POXEL.PA)

EUR 0.48

(4.46%)

Revenue Summary of Poxel S.A.

  • Poxel S.A.'s latest annual revenue in 2023 was 1.98 Million EUR , up 193.92% from previous year.
  • Poxel S.A.'s latest quarterly revenue in 2023 FY was 1.98 Million EUR , up 193.92% from previous quarter.
  • Poxel S.A. reported a annual revenue of 674 Thousand EUR in annual revenue 2022, down -94.97% from previous year.
  • Poxel S.A. reported a annual revenue of 13.39 Million EUR in annual revenue 2021, up 96.84% from previous year.
  • Poxel S.A. reported a quarterly revenue of 1.02 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Poxel S.A. reported a quarterly revenue of 955 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Poxel S.A. (2023 - 2011)

Historical Annual Revenue of Poxel S.A. (2023 - 2011)

Year Revenue Revenue Growth
2023 1.98 Million EUR 193.92%
2022 674 Thousand EUR -94.97%
2021 13.39 Million EUR 96.84%
2020 6.8 Million EUR -74.37%
2019 26.55 Million EUR -64.4%
2018 74.6 Million EUR 1310.26%
2017 5.29 Million EUR 7428.85%
2016 70.26 Thousand EUR 17.8%
2015 59.65 Thousand EUR 0.0%
2014 - EUR 0.0%
2013 - EUR 0.0%
2012 - EUR 0.0%
2011 - EUR 0.0%

Peer Revenue Comparison of Poxel S.A.

Name Revenue Revenue Difference
ABIONYX Pharma SA 4.64 Million EUR 57.306%
ABIVAX Société Anonyme 4.62 Million EUR 57.13%
Adocia SA 2.15 Million EUR 7.86%
Aelis Farma SA 9.05 Million EUR 78.12%
Biophytis S.A. - EUR -Infinity%
Advicenne S.A. 3.15 Million EUR 37.131%
genOway Société anonyme 20.04 Million EUR 90.118%
IntegraGen SA 12.53 Million EUR 84.199%
Medesis Pharma S.A. 300.03 Thousand EUR -560.259%
Neovacs S.A. 533.41 Thousand EUR -271.383%
NFL Biosciences SA - EUR -Infinity%
Plant Advanced Technologies SA 1.68 Million EUR -17.81%
Quantum Genomics Société Anonyme 19.79 Thousand EUR -9907.072%
Sensorion SA 4.74 Million EUR 58.234%
Theranexus Société Anonyme 296.33 Thousand EUR -568.509%
TME Pharma N.V. 17 Thousand EUR -11552.941%
Valbiotis SA 4.73 Million EUR 58.145%
TheraVet SA 1.07 Million EUR -83.757%
Valerio Therapeutics Société anonyme 1.8 Million EUR -10.056%
DBV Technologies S.A. - EUR -Infinity%
Genfit S.A. 28.56 Million EUR 93.065%
GeNeuro SA - EUR -Infinity%
Innate Pharma S.A. 51.9 Million EUR 96.183%
Inventiva S.A. 17.47 Million EUR 88.665%
MaaT Pharma SA 2.22 Million EUR 11.086%
MedinCell S.A. 9.16 Million EUR 78.373%
Nanobiotix S.A. 30.05 Million EUR 93.409%
OSE Immunotherapeutics SA 2.22 Million EUR 11.046%
GenSight Biologics S.A. 1.26 Million EUR -56.354%
Transgene SA 1.18 Million EUR -67.314%
Valneva SE 153.71 Million EUR 98.711%